The FDA still has to act on it, and formal rulemaking takes time - but we're ready to serve patients and providers when a regulatory pathway opens
Importantly, a substantial number of patients had multiple reasons noted for stopping (21%), underscoring the complexity of real-world medication use and the challenges patients face when using these therapies
That's why we focus on comprehensive treatment: the medication jumpstarts weight loss, while lifestyle changes and metabolic improvements help maintain results
Notably, GLP-1R has been reported to be absent in the VMH based on rat immunochemistry and non-human primates ISH studies, warranting caution when extrapolating these findings across species [66,67]
Starting at $ 169 / Month Supports appetite regulation and craving control Naltrexone + Bupropion This non-stimulant combination that can help support your weight management journey by working on brain pathways related to cravings, reward, and appetite regulation
Semaglutide is a powerful tool but not a cure-all